Pityriasis Versicolor

Hu, Stephanie W.; Bigby, Michael

doi:10.1001/archdermatol.2010.259

Cited by 76 publications

(14 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A medical panel recommends the use of fluconazole, if possible, over itraconazole due to drug interactions [ 7 ]. Systematic reviews and meta-analyses confirm that both topical and oral antifungal therapy is superior to placebo treatment; however, there is not sufficient data to assess the efficacy of one treatment over another [ 63 , 65 ]. In practice, physician experience and patient preferences will dictate which treatment is selected.…”

Section: Discussionmentioning

confidence: 99%

Antifungal Treatment for Pityriasis Versicolor

Gupta

Foley

2015

JoF

View full text Add to dashboard Cite

Background: Pityriasis versicolor (PV), also known as tinea versicolor, is caused by Malassezia species. This condition is one of the most common superficial fungal infections worldwide, particularly in tropical climates. PV is difficult to cure and the chances for relapse or recurrent infections are high due to the presence of Malassezia in the normal skin flora. This review focuses on the clinical evidence supporting the efficacy of antifungal treatment for PV. Method: A systematic review of literature from the PubMed database was conducted up to 30 September 2014. The search criteria were “(pityriasis versicolor OR tinea versicolor) AND treatment”, with full text available and English language required. Conclusions: Topical antifungal medications are the first-line treatment for PV, including zinc pyrithione, ketoconazole, and terbinafine. In cases of severe or recalcitrant PV, the oral antifungal medications itraconazole and fluconazole may be more appropriate, with pramiconazole a possible future option. Oral terbinafine is not effective in treating PV and oral ketoconazole should no longer be prescribed. Maintenance, or prophylactic, therapy may be useful in preventing recurrent infection; however, at this time, there is limited research evaluating the efficacy of prophylactic antifungal treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Antifungal Treatment for Pityriasis Versicolor

Gupta

Foley

2015

JoF

View full text Add to dashboard Cite

show abstract

“…Pityriasis versicolor. A wide range of different antifungal drugs is effective in pityriasis versicolor [ 47 ], and cure rates of over 85% can be achieved. Topically applied azole antifungals, such as miconazole, clotrimazole, ketoconazole, and sertaconazole work well in pityriasis versicolor, and there is no difference in results achieved by different antifungal compounds [ 48 ]; most commonly, azole creams are used.…”

Section: Fungal Infections Of the Skinmentioning

confidence: 99%

Therapy of Skin, Hair and Nail Fungal Infections

Hay

2018

JoF

View full text Add to dashboard Cite

Treatment of superficial fungal infections has come a long way. This has, in part, been through the development and evaluation of new drugs. However, utilising new strategies, such as identifying variation between different species in responsiveness, e.g., in tinea capitis, as well as seeking better ways of ensuring adequate concentrations of drug in the skin or nail, and combining different treatment methods, have played equally important roles in ensuring steady improvements in the results of treatment. Yet there are still areas where we look for improvement, such as better remission and cure rates in fungal nail disease, and the development of effective community treatment programmes to address endemic scalp ringworm.

show abstract

“…A yellow-green fluorescence may be observed on examination of affected areas with Wood’s light. [26] Pityriasis alba is another common dermatosis characterized by hypopigmentation, presenting with pale white, well to moderate defined, very slightly scaling plaques. A relationship with sun exposure, xerosis cutis and atopy has been suggested.…”

Section: Localized Hypomelanosesmentioning

confidence: 99%

Hypomelanoses in children

Geel

Speeckaert

Chevolet

et al. 2013

J Cutan Aesthet Surg

View full text Add to dashboard Cite

Hypomelanosis of the skin is a frequently encountered problem in childhood, being totally innocent or representing the first sign of a multisystem disorder. Medical history, clinical examination, Wood’s light investigation, histological analysis of the skin and a multidisciplinary consultation can contribute to a correct and early diagnosis of the different types of hypopigmentations. In the present paper, we present a systematic clinical approach to the differential diagnosis of those skin disorders.

show abstract

Pityriasis Versicolor

Cited by 76 publications

References 67 publications

Antifungal Treatment for Pityriasis Versicolor

Antifungal Treatment for Pityriasis Versicolor

Therapy of Skin, Hair and Nail Fungal Infections

Hypomelanoses in children

Contact Info

Product

Resources

About